*Kenichiro Murata1, Atsuko Hayata1,2,3, Taiga Kikuchi1, Misaki Iwahashi2,3, Ikuko Mohri3, Masaya Tachibana3, Kazuhiro Takuma2,3, Taiichi Katayama3, Masako Taniike3, Hitoshi Hashimoto1,3,4,5,6
(1. Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Science, Osaka University, Osaka, Japan, 2. Department of Pharmacology, Graduate School of Density, Osaka University, Osaka, Japan, 3. Center for Child Mental Development, United Graduate School of Child Development, Osaka University, Osaka, Japan, 4. Institute of Datability Science, Osaka University, Osaka, Japan, 5. Institute for Open and Transdisciplinary Research Initiatives, Osaka University, Osaka, Japan, 6. Department of Molecular Pharmaceutical Science, Graduate School of Medicine, Osaka University, Osaka, Japan)
Keywords:ASD, PGD2, Neurodevelopment, RNA-seq